A Phase 4 interventional study of Prilosec OTC (omeprazole-magnesium) and Prevacid in Healthy, sponsored by Procter and Gamble. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-12-31.
Sponsored by Procter and Gamble · Phase 4, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The objective of this study is to compare Prilosec OTC® to Prevacid® for gastric acid suppression.
Procter and Gamble is the lead sponsor of 83 studies on the registry; none are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 10 (100%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Prilosec OTC
Drug: Prilosec OTC (omeprazole-magnesium)
Prevacid
Drug: Prevacid
Prilosec OTC (omeprazole-magnesium 20.6 mg) tablet to be taken with a glass of water prior to breakfast
Prevacid (15 mg lansoprazole) capsule to be taken with a glass of water prior to breakfast
Mean Percent Time That Gastric pH > 4.0 on Day 5
for 24 hours starting Day 5 for each period
Time frame: 24 hours
This single-center, double-blind, randomized, 2-treatment, 3-period cross-over study conducted in forty healthy adult subjects living in the vicinity of the site.
| Milestone | Prilosec OTC Then Prevacid Then Prevacid | Prevacid Then Prilosec OTC Then Prilosec OTC |
|---|---|---|
| Started | 20 | 20 |
| Completed | 20 | 20 |
| Not completed | 0 | 0 |
| Milestone | Prilosec OTC Then Prevacid Then Prevacid | Prevacid Then Prilosec OTC Then Prilosec OTC |
|---|---|---|
| Started | 20 | 20 |
| Completed | 20 | 20 |
| Not completed | 0 | 0 |
| Milestone | Prilosec OTC Then Prevacid Then Prevacid | Prevacid Then Prilosec OTC Then Prilosec OTC |
|---|---|---|
| Started | 20 | 20 |
| Completed | 20 | 20 |
| Not completed | 0 | 0 |
for 24 hours starting Day 5 for each period
| percent time gastric pH exceeds 4.0 | Prilosec OTC Then Prevacid Then Prevacid | Prevacid Then Prilosec OTC Then Prilosec OTC |
|---|---|---|
| Mean Percent Time That Gastric pH > 4.0 on Day 5 | 36.8 ± 3.45 | 45.7 ± 3.45 |
Non-serious events are listed at a 1% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Prilosec OTC Then Prevacid Then Prevacid | — | 0/40 (0%) | 1/40 (2.5%) |
| Prevacid Then Prilosec OTC Then Prilosec OTC | — | 0/40 (0%) | 2/40 (5%) |
| Event | Prilosec OTC Then Prevacid Then Prevacid | Prevacid Then Prilosec OTC Then Prilosec OTC |
|---|---|---|
| DiarrheaGastrointestinal disorders | 0/40 | 2/40 |
| HeadacheNervous system disorders | 0/40 | 1/40 |
| Skin DiseaseSkin and subcutaneous tissue disorders | 1/40 | 0/40 |
| Age, Categorical(Participants) | Entire Study Population |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 40 |
| >=65 years | 0 |
| Age Continuous(years) | Entire Study Population |
|---|---|
| Mean | 28 ± 6.65 |
| Sex: Female, Male(Participants) | Entire Study Population |
|---|---|
| Female | 12 |
| Male | 28 |
| Region of Enrollment(participants) | Entire Study Population |
|---|---|
| United States | 40 |
The record gives a start of Apr 2009, a primary completion of Jun 2009 and a completion of Jun 2009. It does not say whether these dates are actual or estimated.
Results were first posted in Nov 2010, 1 year 5 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Omeprazole